HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
M Albitar Selected Research
M Albitar Research Topics
Disease
13
Neoplasms (Cancer)
03/2007 - 01/2000
12
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
06/2007 - 01/2000
10
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
02/2009 - 03/2000
8
Myelodysplastic Syndromes (Myelodysplastic Syndrome)
04/2012 - 01/2001
7
Leukemia
04/2004 - 06/2000
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
06/2007 - 01/2000
5
Hematologic Neoplasms (Hematological Malignancy)
03/2007 - 01/2001
4
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
06/2011 - 02/2000
2
Disease Progression
06/2001 - 02/2000
2
Myeloid Leukemia (Leukemia, Myelocytic)
03/2001 - 11/2000
2
Lymphoma (Lymphomas)
06/2000 - 03/2000
1
Aplastic Anemia (Anemia, Hypoplastic)
01/2018
1
Waldenstrom Macroglobulinemia (Macroglobulinemia)
04/2016
1
Paraproteinemias (Monoclonal Gammopathy)
04/2016
1
Multiple Myeloma
04/2012
1
Hairy Cell Leukemia
11/2004
1
Graft vs Host Disease (Graft-Versus-Host Disease)
04/2004
1
Carcinogenesis
08/2003
1
Myeloid Sarcoma (Chloroma)
06/2003
1
Refractory Anemia with Excess of Blasts (RAEM)
11/2002
1
Agranulocytosis (Granulocytopenia)
07/2001
1
Splenomegaly
07/2001
1
Prolymphocytic Leukemia
07/2001
1
Hemorrhage
07/2001
1
Pneumonia (Pneumonitis)
07/2001
1
Hepatomegaly
07/2001
1
Anemia
04/2001
1
Neoplasm Metastasis (Metastasis)
04/2001
1
Autosomal Recessive 3 Severe Congenital Neutropenia
11/2000
1
Retinoblastoma (Glioblastoma, Retinal)
11/2000
1
Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic)
09/2000
1
Necrosis
09/2000
1
Chromosome Aberrations (Chromosome Abnormalities)
04/2000
1
Ataxia Telangiectasia (Louis Bar Syndrome)
03/2000
1
Burkitt Lymphoma (Burkitt's Lymphoma)
01/2000
Drug/Important Bio-Agent (IBA)
5
Proteins (Proteins, Gene)
FDA Link
06/2007 - 03/2000
5
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
04/2001 - 07/2000
3
Phosphotransferases (Kinase)
IBA
06/2011 - 03/2001
3
Hepatocyte Growth Factor (Growth Factor, Hepatocyte)
IBA
08/2001 - 09/2000
3
Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)
IBA
04/2001 - 09/2000
2
Cyclophosphamide (Cytoxan)
FDA Link
Generic
04/2004 - 07/2001
2
DNA (Deoxyribonucleic Acid)
IBA
08/2003 - 01/2003
2
angiogenin
IBA
08/2001 - 01/2001
2
Vincristine (Oncovin)
FDA Link
Generic
07/2001 - 01/2000
2
Dexamethasone (Maxidex)
FDA Link
Generic
07/2001 - 01/2000
2
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
01/2001 - 09/2000
2
Transforming Growth Factor alpha (TGF-alpha)
IBA
01/2001 - 09/2000
2
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
01/2001 - 09/2000
2
DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)
IBA
04/2000 - 01/2000
1
Cell-Free Nucleic Acids
IBA
01/2018
1
Immunoglobulin M (IgM)
IBA
04/2016
1
Erythropoietin
FDA Link
04/2012
1
Syndecan-1 (Syndecan 1)
IBA
02/2009
1
Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)
IBA
06/2007
1
HLA Antigens (Human Leukocyte Antigens)
IBA
03/2007
1
Alemtuzumab (Campath)
FDA Link
04/2004
1
Reactive Oxygen Species (Oxygen Radicals)
IBA
08/2003
1
Mitochondrial DNA (mtDNA)
IBA
08/2003
1
Annexin A5
IBA
11/2002
1
Histidine (L-Histidine)
FDA Link
10/2001
1
Antibodies
IBA
09/2001
1
Surface Antigens (Surface Antigen)
IBA
09/2001
1
Enzymes
IBA
08/2001
1
Glycoproteins (Glycoprotein)
IBA
07/2001
1
Hemoglobins (Hemoglobin)
IBA
07/2001
1
Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
IBA
07/2001
1
Interferons
IBA
06/2001
1
Caspase 3 (Caspase-3)
IBA
06/2001
1
Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)
IBA
04/2001
1
Protein Kinase Inhibitors
IBA
03/2001
1
Proto-Oncogene Proteins c-kit (Proto-Oncogene Protein c-kit)
IBA
03/2001
1
Stem Cell Factor
IBA
03/2001
1
orantinib (SU6668)
IBA
03/2001
1
Semaxinib (SU5416)
IBA
03/2001
1
Epidermal Growth Factor (EGF)
IBA
01/2001
1
Angiogenesis Inhibitors
IBA
01/2001
1
Angiopoietin-1
IBA
01/2001
1
Platelet-Derived Growth Factor
IBA
01/2001
1
Cytokines
IBA
01/2001
1
Transforming Growth Factor beta (TGF-beta)
IBA
01/2001
1
Granulocyte Colony-Stimulating Factor (G-CSF)
IBA
11/2000
1
Granulocyte Colony-Stimulating Factor Receptors (G-CSF Receptor)
IBA
11/2000
1
Retinoblastoma Protein
IBA
11/2000
1
Oncogene Proteins (Oncogene Protein)
IBA
11/2000
1
Tumor Suppressor Protein p14ARF (p14ARF)
IBA
11/2000
1
Cyclin-Dependent Kinase Inhibitor p16
IBA
11/2000
1
Proto-Oncogene Proteins c-mdm2
IBA
11/2000
1
Cyclin D1
IBA
06/2000
1
Immunoglobulins (Immunoglobulin)
IBA
04/2000
1
Messenger RNA (mRNA)
IBA
03/2000
1
Ataxia Telangiectasia Mutated Proteins
IBA
03/2000
1
Retinoic Acid Receptor alpha
IBA
03/2000
1
Thrombopoietin (c-mpl Ligand)
IBA
02/2000
1
Doxorubicin (Adriamycin)
FDA Link
Generic
01/2000
Therapy/Procedure
8
Therapeutics
04/2016 - 02/2000
2
Drug Therapy (Chemotherapy)
08/2003 - 06/2003
1
Stem Cell Transplantation
04/2004
1
Radiotherapy
06/2003